SCHEMBL7777945

SCHEMBL7777945

C#CCn1nc(C(F)(F)F)c(-c2ccc(F)cc2)c1-c1ccc(SC)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 6/20 0.38
GCGR P47871 5/20 0.38
MAPK13 O15264 4/20 0.38
MAPK12 P53778 4/20 0.38
MAPK11 Q15759 4/20 0.38
NR1H2 P55055 5/20 0.36
NR1H3 Q13133 5/20 0.36
KDM4E B2RXH2 1/20 0.36
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRB2 P47870 2/20 0.35
GABRA4 P48169 2/20 0.35
GABRE P78334 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780920 0.80 PTGS2 (0.51) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL7773298 0.79 MAPK14 (0.49) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL8764614 0.74 PTGS2 (0.41) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL7790904 0.72 PTGS2 (0.43) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL7773294 0.67 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL7778238 0.66 PTGS2 (0.60) MAPK14GABRPGABRDGABRA1GABRB1
SCHEMBL7779716 0.65 PTGS2 (0.67) PTGS2PTGS1
SCHEMBL8051549 0.64 MAPK14 (0.46) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL7779945 0.64 MAPK14 (0.46) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL7777683 0.64 MAPK14 (0.49) MAPK14GCGRMAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed